2019 has been off to great gains in our treatment of cancer at CHIPSA Hospital. The CHIPSA Approach™ has been a simple one: forget our ego and preconceived notions of what works in treating cancer, and be open to all possibilities. This includes considering both natural and man-made medications for the treatment of what is now considered […]
Continue reading
Last November, CHIPSA Hospital hosted a unique, first-of-its-kind event celebrating the lives of 22 late stage cancer survivors who, according to doctors, shouldn’t even be alive. Surrounded by world-renowned doctors, scientists, and researchers, these patients shared their inspiring stories of how they healed their terminal disease when conventional treatment had failed them. CHIPSA is not an […]
Continue reading
Cancer relapse is unfortunately all too common in patients who were told their disease was eradicated. We’ve all heard of the patient who receives a clear diagnosis, only to be stricken with cancer yet again. Why is it that the cancer came back? Why didn’t the remission last? This is exactly what […]
Continue reading
John D. was diagnosed with stage 4 squamous cell and basal cell carcinoma in his neck over three years ago. Last year, John had developed a fluid-filled sac on his neck that began to change, harden, and grow. The growth eventually spread throughout […]
Continue reading
Russell W. was given 6 months to live back in 2018 after his non-Hodgkin’s lymphoma spread to his skin. But now, nearly 14 months later, he is alive, well, and eager to share his story. Russell’s journey began when he noticed a swollen lymph node near his elbow back in 2016. […]
Continue reading
Amanda Leverett Davis was diagnosed with an aggressive bone cancer called chondroblastic osteosarcoma in March of 2017. By the time her doctors discovered it, the disease had metastasized and advanced to stage 3. Amanda was told it was non-curative. But nearly two years after her initial diagnosis, Amanda is still alive […]
Continue reading
The KEYNOTE-054 Phase 3 clinical trial (NCT02362594) showed that the immune checkpoint inhibitor drug Keytruda decreased the risk of melanoma recurrence or death by 43% in comparison to a placebo drug. The drug has thus been approved by the U.S. Food and Drug Administration (FDA) to treat patients with stage-3 melanoma (cancer has spread to […]
Continue reading
Amanda L. came to CHIPSA Hospital last October looking for ways to improve her quality of life after surgery, radiation, and chemotherapy failed to treat her late-stage cancer. But she believes CHIPSA did more than that. According to her, not only did they improve her quality of life, they also extended it. Amanda […]
Continue reading
A recent report in the journal Cell showed that a team led by Vanderbilt researchers has found a new “checkpoint” protein on immune system cells in active, malignant tumors. In mouse models, blocking this protein, along with using other treatments, has been an effective approach to treating cancerous cells. Checkpoint proteins are an important component of […]
Continue reading
How Charlotte T. Beat Stage 4 Cancer at CHIPSA Hospital Charlotte T. thought she was out of options when she was diagnosed with Stage-4 inoperable Endometrial cancer in November of 2017. After having a full hysterectomy and 25 rounds of radiation, her doctors told her that the cancer had metastasized to her lungs. There was […]
Continue reading